VALUE-MG Study Update
Thank You to the Myasthenia Gravis Community
The VALUE-MG study has officially reached its recruitment target, with 216 people living with myasthenia gravis participating across five hospital sites in Australia.
This important research is helping build a clearer picture of how myasthenia gravis affects people’s health, daily activities and work over time, and how these experiences link with real-world treatment and healthcare use.
We extend our sincere thanks to every member of the MG community who took part. Your contribution plays a vital role in improving understanding, care and outcomes for people living with MG.
If you are interested in being involved in future myasthenia gravis research, details are included in the infographic below.
